A Phase II open-label study of Olutasidenib Post-Transplant Maintenance Therapy for Patients with IDH1-Mutated Myeloid Malignancies

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Jeremy Ramdial, Kelly Chien, Betül Oran, Rohtesh S. Mehta, Uday Popat, Partow Kebriaei, Katy Rezvani, Gheath Alatrash, George L. Chen, Yago L. Nieto, Abhishek Maiti, Nicholas James Short
+5 more Ghayas C. Issa, Gautam M. Borthakur, Richard E. Champlin, Elizabeth J. Shpall, Courtney Denton Dinardo
DOI: 10.1016/j.jtct.2025.12.586
Cited by: 0

Fields of Study & Subjects

Acute Myeloid Leukemia Research Hematopoietic Stem Cell Transplantation Retinoids in leukemia and cellular processes

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S408–S409
Publication date
1 February 2026
Language
EN